Immunity against mouse thymus-leukemia antigen (TL) protects against development of lymphomas induced by a chemical carcinogen, N-butyl-N-nitrosourea

Kunio Tsujimura, Yuichi Obata, Yasue Matsudaira, Satoshi Ozeki, Osamu Taguchi, Keiko Nishida, Yuko Okanami, Yoshiki Akatsuka, Kiyotaka Kuzushima, Toshitada Takahashi

研究成果: Article

1 引用 (Scopus)

抄録

Mouse thymus-leukemia antigens (TL) are aberrantly expressed on T lymphomas in C57BL/6 (B6) and C3H/He (C3H) mice, while they are not expressed on normal T lymphocytes in these strains. When N-butyl-N-nitrosourea (NBU), a chemical carcinogen, was administered orally to B6 and C3H strains, lymphoma development was slower than in T3b-TL gene-transduced counterpart strains expressing TL ubiquitously as self-antigens, suggesting that anti-TL immunity may play a protective role. In addition, the development of lymphomas was slightly slower in C3H than in B6, which seems to be in accordance with the results of skin graft experiments indicating that both cellular and humoral immunities against TL were stronger in C3H than B6 mice. The interesting finding that B lymphomas derived from a T3b-TL transgenic strain (C3H background) expressing a very high level of TL were rejected in C3H, but not in H-2Kb transgenic mice (C3H background), raises the possibility that TL-specific effector T cell populations are eliminated and/or anergized to a certain extent by interacting with H-2Kb molecules.

元の言語English
ページ(範囲)914-919
ページ数6
ジャーナルCancer science
95
発行部数11
DOI
出版物ステータスPublished - 01-11-2004

Fingerprint

N-nitrosobutylurea
Carcinogens
Immunity
Lymphoma
Inbred C3H Mouse
T-Lymphocytes
thymus-leukemia antigens
Autoantigens
Humoral Immunity
Cellular Immunity

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

これを引用

Tsujimura, Kunio ; Obata, Yuichi ; Matsudaira, Yasue ; Ozeki, Satoshi ; Taguchi, Osamu ; Nishida, Keiko ; Okanami, Yuko ; Akatsuka, Yoshiki ; Kuzushima, Kiyotaka ; Takahashi, Toshitada. / Immunity against mouse thymus-leukemia antigen (TL) protects against development of lymphomas induced by a chemical carcinogen, N-butyl-N-nitrosourea. :: Cancer science. 2004 ; 巻 95, 番号 11. pp. 914-919.
@article{649b9559e9c14ab18b914e050c916910,
title = "Immunity against mouse thymus-leukemia antigen (TL) protects against development of lymphomas induced by a chemical carcinogen, N-butyl-N-nitrosourea",
abstract = "Mouse thymus-leukemia antigens (TL) are aberrantly expressed on T lymphomas in C57BL/6 (B6) and C3H/He (C3H) mice, while they are not expressed on normal T lymphocytes in these strains. When N-butyl-N-nitrosourea (NBU), a chemical carcinogen, was administered orally to B6 and C3H strains, lymphoma development was slower than in T3b-TL gene-transduced counterpart strains expressing TL ubiquitously as self-antigens, suggesting that anti-TL immunity may play a protective role. In addition, the development of lymphomas was slightly slower in C3H than in B6, which seems to be in accordance with the results of skin graft experiments indicating that both cellular and humoral immunities against TL were stronger in C3H than B6 mice. The interesting finding that B lymphomas derived from a T3b-TL transgenic strain (C3H background) expressing a very high level of TL were rejected in C3H, but not in H-2Kb transgenic mice (C3H background), raises the possibility that TL-specific effector T cell populations are eliminated and/or anergized to a certain extent by interacting with H-2Kb molecules.",
author = "Kunio Tsujimura and Yuichi Obata and Yasue Matsudaira and Satoshi Ozeki and Osamu Taguchi and Keiko Nishida and Yuko Okanami and Yoshiki Akatsuka and Kiyotaka Kuzushima and Toshitada Takahashi",
year = "2004",
month = "11",
day = "1",
doi = "10.1111/j.1349-7006.2004.tb02202.x",
language = "English",
volume = "95",
pages = "914--919",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "11",

}

Tsujimura, K, Obata, Y, Matsudaira, Y, Ozeki, S, Taguchi, O, Nishida, K, Okanami, Y, Akatsuka, Y, Kuzushima, K & Takahashi, T 2004, 'Immunity against mouse thymus-leukemia antigen (TL) protects against development of lymphomas induced by a chemical carcinogen, N-butyl-N-nitrosourea', Cancer science, 巻. 95, 番号 11, pp. 914-919. https://doi.org/10.1111/j.1349-7006.2004.tb02202.x

Immunity against mouse thymus-leukemia antigen (TL) protects against development of lymphomas induced by a chemical carcinogen, N-butyl-N-nitrosourea. / Tsujimura, Kunio; Obata, Yuichi; Matsudaira, Yasue; Ozeki, Satoshi; Taguchi, Osamu; Nishida, Keiko; Okanami, Yuko; Akatsuka, Yoshiki; Kuzushima, Kiyotaka; Takahashi, Toshitada.

:: Cancer science, 巻 95, 番号 11, 01.11.2004, p. 914-919.

研究成果: Article

TY - JOUR

T1 - Immunity against mouse thymus-leukemia antigen (TL) protects against development of lymphomas induced by a chemical carcinogen, N-butyl-N-nitrosourea

AU - Tsujimura, Kunio

AU - Obata, Yuichi

AU - Matsudaira, Yasue

AU - Ozeki, Satoshi

AU - Taguchi, Osamu

AU - Nishida, Keiko

AU - Okanami, Yuko

AU - Akatsuka, Yoshiki

AU - Kuzushima, Kiyotaka

AU - Takahashi, Toshitada

PY - 2004/11/1

Y1 - 2004/11/1

N2 - Mouse thymus-leukemia antigens (TL) are aberrantly expressed on T lymphomas in C57BL/6 (B6) and C3H/He (C3H) mice, while they are not expressed on normal T lymphocytes in these strains. When N-butyl-N-nitrosourea (NBU), a chemical carcinogen, was administered orally to B6 and C3H strains, lymphoma development was slower than in T3b-TL gene-transduced counterpart strains expressing TL ubiquitously as self-antigens, suggesting that anti-TL immunity may play a protective role. In addition, the development of lymphomas was slightly slower in C3H than in B6, which seems to be in accordance with the results of skin graft experiments indicating that both cellular and humoral immunities against TL were stronger in C3H than B6 mice. The interesting finding that B lymphomas derived from a T3b-TL transgenic strain (C3H background) expressing a very high level of TL were rejected in C3H, but not in H-2Kb transgenic mice (C3H background), raises the possibility that TL-specific effector T cell populations are eliminated and/or anergized to a certain extent by interacting with H-2Kb molecules.

AB - Mouse thymus-leukemia antigens (TL) are aberrantly expressed on T lymphomas in C57BL/6 (B6) and C3H/He (C3H) mice, while they are not expressed on normal T lymphocytes in these strains. When N-butyl-N-nitrosourea (NBU), a chemical carcinogen, was administered orally to B6 and C3H strains, lymphoma development was slower than in T3b-TL gene-transduced counterpart strains expressing TL ubiquitously as self-antigens, suggesting that anti-TL immunity may play a protective role. In addition, the development of lymphomas was slightly slower in C3H than in B6, which seems to be in accordance with the results of skin graft experiments indicating that both cellular and humoral immunities against TL were stronger in C3H than B6 mice. The interesting finding that B lymphomas derived from a T3b-TL transgenic strain (C3H background) expressing a very high level of TL were rejected in C3H, but not in H-2Kb transgenic mice (C3H background), raises the possibility that TL-specific effector T cell populations are eliminated and/or anergized to a certain extent by interacting with H-2Kb molecules.

UR - http://www.scopus.com/inward/record.url?scp=19944422078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19944422078&partnerID=8YFLogxK

U2 - 10.1111/j.1349-7006.2004.tb02202.x

DO - 10.1111/j.1349-7006.2004.tb02202.x

M3 - Article

C2 - 15546510

AN - SCOPUS:19944422078

VL - 95

SP - 914

EP - 919

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 11

ER -